AI Proteins

One-liner: AI Proteins develops AI-driven solutions for creating protein-based medicines aimed at the biotechnology and pharmaceutical sectors.

Company slogan: “better medicines, created rapidly through de novo protein design”

Positioning: “AI Proteins is positioned as an innovative player in the protein-based medicine sector, utilizing advanced technologies to create novel therapeutic solutions.”

Description: “Boston-based AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-based design and a high-throughput drug discovery platform, AI Proteins creates de novo proteins optimized for specific therapeutic applications. The AI Proteins platform enables the development of inexpensive, durable, highly specific proteins that have the potential for oral delivery. Additionally, the AI Proteins platform can dramatically accelerate the development of lead therapeutic candidates ready for IND enabling studies.”

Employees: 44

Website: Visit website

Headquarters: “Boston, Massachusetts”

Ownership: Privately Held

Founded: 2021

Company type: AI company

Use cases: “drug development, protein design, therapeutic innovations”

Pricing: not specified

Client sector: “biotechnology, pharmaceuticals”

Business model: not specified

Products: “miniproteins, therapeutic candidates”

Is API available: no

Website title: AI Proteins

Website description: Harnessing the power of synthetically designed proteins to cure diseases

Linkedin: https://www.linkedin.com/company/aiproteins

Youtube: –

Instagram: https://www.instagram.com/aiproteins/

Facebook: –

Twitter: https://twitter.com/AI_Proteins

Crunchbase: https://www.crunchbase.com/organization/ai-proteins

Email: –